Crossref
Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen
Uirusu · 2023
DOI: 10.2222/jsv.72.149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Uirusu, 2023. Verfasst von Takanobu Kato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan. Hauptthemen laut MEDLINE: Hepatitis B virus, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Hepatitis B virusHepatitis BAnimalsHepatitis B VaccinesHepatitis B Surface AntigensMacaca mulattaSaccharomyces cerevisiaeHepatitis B AntibodiesMutation
Substanzen
Hepatitis B VaccinesHepatitis B Surface AntigensHepatitis B Antibodies
Autor:innen und Institutionen
- Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
- Center for the Evolutionary Origins of Human Behavior, Kyoto University, Aichi, Japan.
Zitieren
APA
Kato, T., & Akari, H. (2023). Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen. Uirusu. https://doi.org/10.2222/jsv.72.149
Vancouver
Kato T, Akari H. Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen. Uirusu. 2023. doi:10.2222/jsv.72.149
BibTeX
@article{Kato2023,
author = {Kato, Takanobu and Akari, Hirofumi},
title = {Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen},
journal = {Uirusu},
year = {2023},
doi = {10.2222/jsv.72.149}
}
EUVIMED